Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
alanine, ALT, aminotransferase, antitumor, Antonio, area, aspartate, AST, baseline, bilirubin, CI, Confidence, diarrhea, dysfunction, erythrodysaesthesia, ESMO, faster, headcount, hyperglycemia, infrequent, Interval, invasive, lipase, MOUNTAINEER, multinational, muscle, NDA, PPE, qualification, RAS, ratio, RECIST, San, sensory, shrank, supplier, Symposium, tolerability, tolerated, topline, vomiting
Removed:
adriamycin, afford, collaborating, CTCL, dual, MF, pcALCL, preclude
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view